These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 2942331
1. Platelet and vessel wall interaction and the genesis of atherosclerosis. Chesterman CN, Berndt MC. Clin Haematol; 1986 May; 15(2):323-53. PubMed ID: 2942331 [Abstract] [Full Text] [Related]
4. [Thrombocyte-vascular wall interaction and coronary heart disease]. Lüscher TF. Schweiz Med Wochenschr; 1991 Dec 28; 121(51-52):1913-22. PubMed ID: 1763300 [Abstract] [Full Text] [Related]
5. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)]. Tobelem G, Drouet L, Caen J. Nouv Presse Med; 1980 Mar 15; 9(13):949-54. PubMed ID: 6987618 [Abstract] [Full Text] [Related]
6. Platelet-vessel wall interaction in health and disease. Löwenberg EC, Meijers JC, Levi M. Neth J Med; 2010 Jun 15; 68(6):242-51. PubMed ID: 20558854 [Abstract] [Full Text] [Related]
7. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ. J Clin Invest; 1994 Jan 15; 93(1):204-11. PubMed ID: 8282789 [Abstract] [Full Text] [Related]
8. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Hoylaerts MF. Verh K Acad Geneeskd Belg; 1997 Jan 15; 59(3):161-83. PubMed ID: 9490916 [Abstract] [Full Text] [Related]
9. [Role of the von Willebrand factor in the physiopathology of primary hemostasis]. Dmoszyńska-Giannopoulou A. Pol Tyg Lek; 1983 Nov 28; 38(48):1519-21. PubMed ID: 6089153 [No Abstract] [Full Text] [Related]
10. [Thrombogenic properties of the vessel and their inhibition]. Cazenave JP, Klein-Soyer C, Beretz A. Nouv Rev Fr Hematol (1978); 1982 Nov 28; 24(3):167-71. PubMed ID: 6752880 [Abstract] [Full Text] [Related]
11. The role of platelets in the development and complications of atherosclerosis. Packham MA, Mustard JF. Semin Hematol; 1986 Jan 28; 23(1):8-26. PubMed ID: 3511536 [Abstract] [Full Text] [Related]
12. Platelets and chemokines in atherosclerosis: partners in crime. Weber C. Circ Res; 2005 Apr 01; 96(6):612-6. PubMed ID: 15802619 [Abstract] [Full Text] [Related]
13. Role of the von Willebrand factor in atherogenesis. Green D. Artery; 1979 Mar 01; 5(3):262-72. PubMed ID: 316693 [Abstract] [Full Text] [Related]
14. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Nat Med; 2003 Jan 01; 9(1):61-7. PubMed ID: 12483207 [Abstract] [Full Text] [Related]
15. Molecular defects in interactions of platelets with the vessel wall. George JN, Nurden AT, Phillips DR. N Engl J Med; 1984 Oct 25; 311(17):1084-98. PubMed ID: 6384783 [Abstract] [Full Text] [Related]
16. Platelet interaction with the vessel wall. de Groot PG, Urbanus RT, Roest M. Handb Exp Pharmacol; 2012 Oct 25; (210):87-110. PubMed ID: 22918728 [Abstract] [Full Text] [Related]
19. The role of platelet membrane glycoproteins in the adhesion of blood platelets. Sixma JJ. Agents Actions Suppl; 1986 Oct 25; 20():15-26. PubMed ID: 3544740 [No Abstract] [Full Text] [Related]